News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
628,363 Results
Type
Article (31737)
Company Profile (620)
Press Release (596006)
Section
Business (196218)
Career Advice (2048)
Deals (36117)
Drug Delivery (80)
Drug Development (77100)
Employer Resources (160)
FDA (15227)
Job Trends (14633)
News (330429)
Policy (28713)
Tag
Academia (1375)
Africa (658)
Alabama (32)
Allergies (38)
Alliances (46445)
Alzheimer's disease (1031)
Antibody-drug conjugate (ADC) (51)
Approvals (15178)
Arizona (93)
Artificial intelligence (47)
Asia (38778)
Australia (6275)
Bankruptcy (363)
Best Places to Work (10534)
Biosimilars (48)
C2C Services and Suppliers (72920)
California (810)
Canada (638)
Cancer (170)
Career advice (1689)
CAR-T (32)
Cell therapy (63)
China (48)
Clinical research (60359)
Collaboration (58)
Colorado (30)
COVID-19 (2060)
Cystic fibrosis (65)
Diabetes (31)
Diagnostics (5869)
Diversity, equity & inclusion (37)
Drug pricing (51)
Earnings (79276)
Employer resources (134)
Europe (83887)
Events (104288)
Executive appointments (28)
FDA (15272)
Florida (75)
Funding (38)
Gene therapy (46)
GLP-1 (477)
Government (2784)
Healthcare (16265)
Hotbed/Location (440190)
Idaho (54)
Illinois (156)
Indiana (105)
Infectious disease (2070)
Inflammatory bowel disease (80)
Interviews (416)
IPO (16793)
Job creations (4205)
Job search strategy (1422)
Kansas (86)
Layoffs (431)
Legal (7067)
Liver cancer (51)
Lung cancer (38)
Maine (49)
Management (54)
Manufacturing (52)
Maryland (192)
Massachusetts (460)
Medical device (13274)
Medtech (13277)
Mergers & acquisitions (19008)
Metabolic disorders (153)
Neuroscience (1117)
New Jersey (62)
New York (77)
NextGen Class of 2024 (6030)
Non-profit (2029)
North Carolina (168)
Obesity (99)
Opinion (202)
Parkinson's disease (31)
Patents (36)
Peanut (34)
Pennsylvania (50)
People (55162)
Phase I (18920)
Phase II (27000)
Phase III (20048)
Policy (35)
Postmarket research (1909)
Preclinical (7618)
Rare diseases (85)
Real estate (5738)
Recruiting (62)
Regulatory (19501)
Research institute (1345)
Resumes & cover letters (324)
South America (1043)
Startups (3855)
Texas (86)
United States (2799)
Vaccines (377)
Washington State (115)
Weight loss (98)
Date
Today (43)
Last 7 days (484)
Last 30 days (1884)
Last 365 days (38991)
2024 (22178)
2023 (40461)
2022 (50926)
2021 (54155)
2020 (51209)
2019 (42404)
2018 (32402)
2017 (32567)
2016 (30786)
2015 (36175)
2014 (28870)
2013 (23834)
2012 (25445)
2011 (25609)
2010 (23452)
628,363 Results for "staar surgical company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference.
June 5, 2024
·
1 min read
Business
STAAR Surgical Reports First Quarter 2024 Results
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, reported financial results for the first quarter ended March 29, 2024.
May 7, 2024
·
19 min read
Business
STAAR Surgical to Report First Quarter Results on May 7, 2024
STAAR Surgical Company today announced that it will release financial results for the first quarter ended March 29, 2024, on Tuesday, May 7, 2024, after the market close.
April 29, 2024
·
2 min read
Business
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
STAAR Surgical Company announces another milestone achieved on its U.S. Highway 93 go-to-market program – a strategic agreement with IQ Laser Vision, a leader in providing clear vision to clients with locations across California and Texas, and a top EVO ICL practice in North America.
May 7, 2024
·
9 min read
Business
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
STAAR Surgical Company today announced preliminary net sales for the first quarter ended March 29, 2024, are expected to be in excess of $77 million with U.S. ICL sales expected to be $5 million for the quarter.
April 4, 2024
·
4 min read
Biotech Beach
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, announced that more than three million ICLs have been sold globally.
March 18, 2024
·
3 min read
Business
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel.
May 1, 2024
·
4 min read
Business
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
STAAR Surgical Company today announced that it will release financial results for the fourth quarter ending December 29, 2023, on Monday, February 26, 2024, after the market close.
February 19, 2024
·
2 min read
Business
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
STAAR Surgical Company announced the appointment of Arthur Butcher, Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, and Wei Jiang, retired Executive Vice President and President of Bayer Pharmaceuticals Region China & APAC, to its Board of Directors, effective March 12, 2024.
March 12, 2024
·
4 min read
Business
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, reported financial results for the fourth quarter and fiscal year ended December 29, 2023.
February 26, 2024
·
22 min read
1 of 62,837
Next
